Below are the valuation targets for Cardinal Health (CAH) for the next 10 years.
Our valuation targets for Cardinal Health (CAH) in 2021 are:
-
$95.74 (overvalued)
-
$73.87 (fair value)
-
$52.00 (undervalued)
-
$34.02 (extreme undervalue)
The valuation targets for Cardinal Health (CAH) are based on a dividend growth rate of 2.50% which is derived from the lowest calculated growth rated as indicated on the Value Line Investment Survey dated February 12, 2021 and applied to Edson Gould’s Altimeter. A graphical representation of the overvalued, fair value, and undervalued levels are below.
The above Altimeter translates into the following undervalued and overvalued ranges since 2008:
10-Year Targets
Observations
According to Value Line Investment Survey, Cardinal Health (CAH) has an expected price range of $90-$135 by 2024-2026. On our end, we have a range from as low as $56.00 to as high as $108.32 in the same period of time.
Last updated: April 2, 2021